Biomarker Expression and Risk of Subsequent Tumors After Initial Ductal Carcinoma In Situ Diagnosis

2010348 citationsJournal Articlebronze Open Access

Authors

Karla Kerlikowske · Princess Margaret Cancer Centre

Annette M. Molinaro · University of California, San Francisco

Marie-Pier Gauthier · University of California, San Francisco

Hal K. Berman · Princess Margaret Cancer Centre

F. Waldman · UCSF Helen Diller Family Comprehensive Cancer Center

James L. Bennington · California Pacific Medical Center

Henry Sánchez

Abstract

Biomarkers can identify which women who were initially diagnosed with DCIS are at high or low risk of subsequent invasive cancer, whereas histopathology information cannot.

Topics & Keywords

Breast Cancer Treatment Studies Breast Lesions and Carcinomas HER2/EGFR in Cancer Research

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: JNCI Journal of the National Cancer Institute

Volume 102, Issue 9, pp. 627-637

DOI: 10.1093/jnci/djq101

Field-Weighted Citation Impact: 14.60